Vol. 9 No. 1 (2022): January-December 2022

Published: 2022-12-31

Full Issue

Editorial

  • New trends in clinical trials—between complexity and the need for renewal

    Celeste Cagnazzo
    42-44
    DOI: https://doi.org/10.33393/ao.2022.2437

  • Introducing the “How to …” review article series

    Giacomo Bellani, Giulio Zuanetti
    10
    DOI: https://doi.org/10.33393/ao.2022.2411

  • Altmetrics, Beamplots, Plum X Metrics and friends: discovering the new waypoints in the Science Metrics roadmap

    Valeria Scotti
    1-2
    DOI: https://doi.org/10.33393/ao.2022.2363

Review

  • A roadmap for building your scientific reputation on social media

    Vittorio Iacovella
    87-91
    DOI: https://doi.org/10.33393/ao.2022.2468

Point of view

  • What will remain of the Impact Factor?

    Valeria Scotti
    45-46
    DOI: https://doi.org/10.33393/ao.2022.2467

  • Guideline proposal for pharma companies to manage pharmacovigilance activities in digital media

    Daniela Bernardini, Ilenia Bocchi, Stefano Bonato, Davide Bottalico, Valentina Calderazzo, Carmela Casino, Gian Nicola Castiglione, Carla Cottone, Stefania Dellon, Ilaria Grisoni, Amanda Mattavelli, Giacomo Pirisino, Silvia Romano, Grazia Sirizzotti, Lisa Stagi, on behalf of the SIMeF Working Group
    21-28
    DOI: https://doi.org/10.33393/ao.2022.2401

  • A mixed reality telemedicine system for collaborative ultrasound diagnostics and ultrasound-guided interventions

    Stefan Maas, Peter Kopacsi, Peter Kovacs, Arnaud Bosteels
    15-20
    DOI: https://doi.org/10.33393/ao.2022.2394

Original research articles

  • Model for estimating the impact of healthcare costs in non-hospitalized Covid-19 patients treated with remdesivir

    Matteo Ruggeri, Alessandro Signorini, Silvia Caravaggio, Marco Falcone, Giovanni Di Perri
    114-121
    DOI: https://doi.org/10.33393/ao.2022.2473

  • Savings associated with therapeutic appropriateness for patients with relapsed refractory multiple myeloma and high cytogenetic risk diagnosed by FISH test

    Rossella Bitonti, Federica Demma, Massimiliano Rea, Gianluca Furneri
    105-111
    DOI: https://doi.org/10.33393/ao.2022.2447

  • Cost-utility analysis of brigatinib compared to alectinib in the treatment of ALK-positive NSCLC in patients previously not treated with an ALK inhibitor

    Roberto Ravasio, Holly Cranmer, Izzie Kearns , Raffaella Viti, Simone Corinti
    92-104
    DOI: https://doi.org/10.33393/ao.2022.2450

  • Cost analysis comparison of rurioctocog alfa pegol compared to turoctocog alfa pegol in the prophylaxis of Haemophilia A in Italy

    Federica Demma, Pierpaola Arpa
    36-42
    DOI: https://doi.org/10.33393/ao.2022.2405

  • Psoriasis at the time of COVID-19: results of an Italian survey on patients and caregivers

    Valeria Dealessi, Giovanni Gigante, Claudia Leporati, Ugo G. Viora
    29-35
    DOI: https://doi.org/10.33393/ao.2022.2393

  • Health Policy Brief: i pilastri dell’Engagement in Emofilia

    Guendalina Graffigna, Serena Barello, Caterina Bosio, Chiara Biasoli, Andrea Buzzi, Cristina Cassone, Luigi Ambroso, Patrizia Di Gregorio, Lorenzo Farace, Paola Giordano, Renato Marino, Irene Ricca, Angiola Rocino
    3-9
    DOI: https://doi.org/10.33393/ao.2022.2319

How to

  • How to insert a PICC: practical tips for the intensive care physician

    Stefano Elli, Giacomo Bellani, Alberto Lucchini
    11-14
    DOI: https://doi.org/10.33393/ao.2022.2360

Focus on the management of critical bleeding

  • Classical and Point-of-Care tests in severe hemorrhage management

    Paolo Simioni
    47-51
    DOI: https://doi.org/10.33393/ao.2022.2433

  • Plasma, platelets and cryoprecipitates therapies

    Vanessa Agostini
    52-57
    DOI: https://doi.org/10.33393/ao.2022.2432

  • Sepsis-induced coagulopathy and disseminated intravascular coagulation

    Antonino Giarratano
    58-60
    DOI: https://doi.org/10.33393/ao.2022.2434

  • Major obstetric hemorrhage management

    Maria Grazia Frigo
    61-65
    DOI: https://doi.org/10.33393/ao.2022.2426

  • Management of bleeding in cardiac surgery patients

    Marco Ranucci
    66-69
    DOI: https://doi.org/10.33393/ao.2022.2435

  • Coagulopathy and hemorrhage management in major abdominal surgery

    Cristiano Piangatelli
    70-72
    DOI: https://doi.org/10.33393/ao.2022.2424

  • Coagulopathy and hemorrhage management in cirrhotic patients

    Giandomenico Biancofiore
    73-76
    DOI: https://doi.org/10.33393/ao.2022.2436

  • Trauma-induced coagulopathy management

    Maria Grazia Bocci
    77-82
    DOI: https://doi.org/10.33393/ao.2022.2425

Case report

  • Emicizumab in hemophilia A with inhibitors: clinical and economic impact of its use in a Cuban patient

    Dunia Castillo-Gonzàles, Irianys Álvarez Sardiñas, Consuelo Macías Abraham, Alex G. Muñoz Bedoya
    83-86
    DOI: https://doi.org/10.33393/ao.2022.2438

Correspondence